Invivyd

About:

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Website: https://invivyd.com/

Twitter/X: invivyd

Top Investors: OrbiMed, RA Capital Management, Fidelity, Google Ventures, Foresite Capital

Description:

Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2.

Total Funding Amount:

$466M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)invivyd.com

Founders:

Laura Walker, Tillman Gerngross

Number of Employees:

51-100

Last Funding Date:

2021-04-19

IPO Status:

Public

© 2025 bioDAO.ai